Cargando…
Newly Engineered Magnetic Erythrocytes for Sustained and Targeted Delivery of Anti-Cancer Therapeutic Compounds
Cytotoxic chemotherapy of cancer is limited by serious, sometimes life-threatening, side effects that arise from toxicities to sensitive normal cells because the therapies are not selective for malignant cells. So how can they be selectively improved? Alternative pharmaceutical formulations of anti-...
Autores principales: | Cinti, Caterina, Taranta, Monia, Naldi, Ilaria, Grimaldi, Settimio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044154/ https://www.ncbi.nlm.nih.gov/pubmed/21373641 http://dx.doi.org/10.1371/journal.pone.0017132 |
Ejemplares similares
-
Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study
por: Naldi, Ilaria, et al.
Publicado: (2014) -
Time-course gene profiling and networks in demethylated retinoblastoma cell line
por: Malusa, Federico, et al.
Publicado: (2015) -
Ensemble inference by integrative cancer networks
por: Mora, Antonio, et al.
Publicado: (2014) -
Erythro–Magneto–HA–Virosome: A Bio-Inspired Drug Delivery System for Active Targeting of Drugs in the Lungs
por: Vizzoca, Alessio, et al.
Publicado: (2022) -
Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line
por: Capobianco, Enrico, et al.
Publicado: (2014)